Morningstar alternatives

Morningstar alternatives for stock screening, Europe included.

Morningstar Investor is one of the most trusted names in investment research — star ratings, analyst reports, and deep US equity coverage. But European small cap screening is thin, the workflow is built around reading reports rather than applying filters, and it costs $34.95/month. If active filter-driven screening is your primary workflow, these alternatives are more efficient.

Updated October 2026 · 5 alternatives reviewed

What a screening-first tool gives you over Morningstar

Filter-driven workflow

Morningstar is built for reading analyst reports and star ratings. ScreenerHero is built for applying filters and getting a ranked table of results — a fundamentally different workflow for active stock discovery.

European coverage that works

Morningstar's European coverage is US-first in practice — small and microcap European names have thin data. ScreenerHero covers all European exchanges including microcaps with consistent fundamental data.

No monthly fee

Morningstar Investor is $34.95/month. The ScreenerHero paid plan is a one-time Lifetime payment, for a tool built entirely around filtering rather than report-reading.

Free core screener

Test the filter depth and European coverage with no account required before paying anything. No trial period — the core screener stays free.

What to look for in a Morningstar alternative

Screener vs. research tool

Is the product built around applying filters to discover stocks, or around reading analyst reports and ratings? These are different workflows and different products.

European small cap coverage

Morningstar's strength is US large caps. Does the alternative have populated fundamental data for European small and microcap names — not just the top 500 European companies?

Filter depth

How many filters can you combine simultaneously, and across which geographies? Morningstar's screener allows basic filtering but is not built for multi-criteria stock discovery.

Output density

Results should be a sortable table with dozens of columns — not a report browser or a card layout with limited columns.

Price relative to workflow

If you rarely read analyst reports, you should not pay for them. Match the subscription cost to what you actually use.

The 5 best Morningstar alternatives for active stock screening (2026)

Top pick— ranked #1

ScreenerHero

Filter-driven screening. US + Canada + Europe + Australia. No subscription.

Free / Lifetime (97€ once)

ScreenerHero is built around the screener, not analyst reports. Filter by 40+ fundamental and technical criteria across US, Canadian, Australian, and all European equities — including microcaps — and get results in a dense, sortable table you can act on immediately. Paid access is a one-time Lifetime payment, where Morningstar Investor is $34.95/month, with broader geographic coverage and a free core tier that requires no account.

Markets

US, Canada, Australia, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges

Screener filters

P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield

UI style

Desktop-first, data-dense, built around the screener

Heatmap

Yes

Open ScreenerHero free
#2

Finviz

The benchmark for dense US screening — no meaningful European coverage

Free limited / $39.50/mo Elite

Finviz is built entirely around the screener — the opposite of Morningstar. Elite at $39.50/month is more expensive than Morningstar Investor but the UX is significantly more efficient for filter-driven screening. Coverage is US-only; European exchanges are not part of the product. The free tier is genuinely useful for US screening.

Markets

US primarily

Screener filters

P/E, P/B, ROE, margins, momentum — US equities only

UI style

Desktop-first, data-dense, screener-first

Heatmap

Yes

#3

Stockopedia

Score-driven research for European equities — expensive, research-oriented

€60/mo EU · €80/mo US+EU

Stockopedia sits in a similar research-oriented segment as Morningstar — it is built around StockRanks composite scores rather than raw filter sliders. The European coverage (UK-weighted, some continental) is stronger than Morningstar. At €60–80/month it is significantly more expensive than ScreenerHero and still does not include Canada.

Markets

UK-weighted, some continental Europe (no Canada)

Screener filters

StockRanks composite (QVM) + custom filters

UI style

Card-based, research-oriented

Heatmap

No

#4

Koyfin

Professional charting and dashboards — screener is secondary

Free limited / $39/mo Plus

Koyfin Plus is $39/month and built around charting and dashboards rather than research reports. Global fundamental coverage is broader than Morningstar for screening purposes — but the screener is still secondary to the charting infrastructure. European microcap coverage has gaps. Better value than Morningstar for active screeners.

Markets

US + global (large and mid cap focus)

Screener filters

Fundamentals, macroeconomic overlays

UI style

Dashboard-first, chart-oriented

Heatmap

No

#5

TIKR

Broad global coverage, value-investor focus — less dense UI

$10–15/mo Plus · $40–55/mo Pro

TIKR attracts a similar value-investor audience to Morningstar, but the product is built around data access rather than analyst ratings. TIKR Plus starts at $25/month — significantly cheaper than Morningstar Investor. Pro runs $40–55/month and includes 20-year financial history and earnings transcripts. European microcap coverage is a known gap.

Markets

100k+ stocks, 92 countries

Screener filters

Fundamentals, historical financials, transcripts on Pro

UI style

Data-focused, less dense UI

Heatmap

No

Quick comparison

ScreenerHeroMorningstarFinvizStockopediaKoyfin
US coverage
Canadian coverage
European coverage
Microcap EU coverage
Screener-first UX
Dense table UI
Heatmap
Free core features
No account required
Paid plan (from)97€ once$34.95/mo$39.50/mo€60/mo$39/mo
Legend:StrongPartialAbsent

Recommendation by use case

You want to actively screen US, Canadian, European & Australian stocks by fundamentals

ScreenerHero — screening-first, free core screener, full EU microcap depth, one-time paid plan.

You rely on analyst star ratings and written research reports for US equities

Morningstar Investor — the ratings methodology and report quality are unmatched for US large caps. Accept the thin European coverage and report-centric workflow.

You screen US stocks only and want the densest filter experience

Finviz — the benchmark for US screening density. $39.50/month for Elite.

You prefer composite scores and invest primarily in UK and European equities

Stockopedia — well-regarded StockRanks methodology. Accept €60–80/month and coverage limitations.

You want global reach at the lowest price

TIKR Plus — $25/month, wide reach, accept European microcap gaps and less dense UI.

What Morningstar does better than any alternative

Economic moat analysis. The wide, narrow or no-moat rating is an analyst-driven judgement of how durable a competitive advantage is. No screener replicates it, because it takes analyst judgement, not just data.

Fair value estimates. Analyst-made fair values for thousands of stocks give a reference point for intrinsic value without building your own model.

Fund star ratings. For mutual funds and ETFs, Morningstar’s ratings and analyst picks are the industry standard, with no credible free equivalent.

Portfolio X-ray, which looks through fund holdings to show true diversification, sector exposure and style. If any of these is central to your process, Morningstar remains the right tool; if you mainly filter stocks, a screener does that job faster.

Frequently asked questions

Is there a free Morningstar alternative for stock research?

Stock Analysis offers long financial histories for free. ScreenerHero's free tier covers systematic screening across US, Canadian, European and Australian exchanges, and Finviz covers US stocks free without an account. None replicates Morningstar's analyst ratings or fair value estimates, but together they cover the financial data and screening for free.

Is Morningstar good for stock screening?

Its stock screener works, but it is not built for fast, systematic screening, and it lacks the speed and filter depth of dedicated screeners (Finviz for the US, ScreenerHero for Europe and beyond). Morningstar's advantage is analyst research and fund analysis; the screener is secondary.

Which Morningstar alternative has the best European coverage?

ScreenerHero, including growth markets such as Euronext Growth Paris, Nasdaq First North, Euronext Growth Milan and NewConnect in Warsaw, which most screeners, Morningstar included, cover poorly below large caps.

Can I use ScreenerHero instead of Morningstar?

For stock screening (filtering by P/E, ROE, EV/EBITDA, margins and dividends across markets), yes. For Morningstar's analyst research (moat ratings, fair value estimates), fund star ratings and fund-level portfolio analytics, no: ScreenerHero does not replicate those. It depends on which part of Morningstar you actually use.

Less than Morningstar. Built for screening.

Dense tables. Fast filters. Heatmap. US, Canadian, European & Australian equities — including microcaps — in one screening-first tool. Free, no account needed. Lifetime access is a one-time 97€ payment — no subscription.